GPX4 and Parkinson disease: Evidence for ferroptosis activity, including increased LPO, increased iron stores, decreased GPX4, and decreased glutathione, is present in several CNS diseases, such as Alzheimer’s disease and Parkinson’s disease [13,19,29].